Publication
Ferroportin Disease (Haemochromatosis-type IV): a case report
| dc.contributor.author | Novo, Elena | |
| dc.contributor.author | Faria, Ricardo | |
| dc.contributor.author | Faustino, Paula | |
| dc.contributor.author | Fleming, Rita | |
| dc.date.accessioned | 2016-05-25T11:56:19Z | |
| dc.date.available | 2016-05-25T11:56:19Z | |
| dc.date.issued | 2016-04 | |
| dc.description.abstract | Introdution: Haemochromatosis-type IV, the ferroportin disease, is characterized by an autosomal-dominant transmission and early iron accumulation in macrophages. It is caused by mutations in the transmembrane iron exporter protein ferroportin1 (SLC40A1 gene). In form A (classic), ferroportin loss of function mutants are unable to export iron from cells leading to cellular iron accumulation with decreased availability of iron for serum transferrin (TS). We present a Portuguese rare clinical case of HH-IV. Materials and Methods: A 41-year-old woman with hyperferritinemia and normal TS. Causes of hyperferritinemia (inflammation, chronic alcohol consumption, metabolic syndrome, cell necrosis, non-alcoholic fatty liver disease and aceruloplasminemia) were assessed. Liver iron, evaluated by magnetic resonance imaging (MRI) was carried out. Screening for mutation in HFE and SCL40A1 genes were performed by Sanger sequencing. Baseline: Ferritin:708ng/ml; TS: 27%; MRI:85µmol/g; Hb:13,6g/dl. Therapy: weekly 450ml Therapeutic Phlebotomies (TP) until ferritin≤50ng/ml. Results: Hyperferritinemia comorbidities and common genetic mutations for haemochromatosis were negative. However, sequencing of the patient SLC40A1 gene has revealed the presence in heterozygosity of the variant c.238G>A; p.Gly80Ser. Due to low tolerance to TP, we adopted smaller phlebotomies every three weeks. Conclusion: This patient has a rare autosomal-dominant Ferroportin disease due to a mutated ferroportin which is predicted to be defective in iron cellular export. In agreement, she presents hyperferritinemia, with normal TS and liver iron overload. The genotype/phenotype association allowed to diagnosis this rare FD case. Although a mild form A, we decided to start TP. Her father also has been treated for iron overload. | pt_PT |
| dc.identifier.uri | http://hdl.handle.net/10400.18/3820 | |
| dc.language.iso | eng | pt_PT |
| dc.peerreviewed | yes | pt_PT |
| dc.subject | Metabolismo do Ferro | pt_PT |
| dc.subject | Hemocromatose Hereditátia | pt_PT |
| dc.subject | Ferroportina | pt_PT |
| dc.subject | FTL | pt_PT |
| dc.subject | Doenças Genéticas | pt_PT |
| dc.title | Ferroportin Disease (Haemochromatosis-type IV): a case report | pt_PT |
| dc.type | conference object | |
| dspace.entity.type | Publication | |
| oaire.citation.conferencePlace | Innsbruck, Austria | pt_PT |
| oaire.citation.title | European Iron Club 2016, April 7-10 2016 | pt_PT |
| rcaap.rights | openAccess | pt_PT |
| rcaap.type | conferenceObject | pt_PT |